Controlling how platelets are made in the bone marrow

The Centrosome as a master controller of platelet production.

NIH-funded research Boston Children's Hospital · NIH-11317217

Testing whether targeting the centrosome and its cell machinery can help people with low platelet counts make more platelets.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBoston Children's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11317217 on NIH RePORTER

What this research studies

From my perspective as a patient, this work looks at the bone marrow cells called megakaryocytes that produce platelets and asks how their internal parts trigger platelet release. The team uses high-content microscopy and image analysis to watch proplatelet formation and screens small molecules and signaling pathways that change platelet production. Much of the work is done in the lab on cells and engineered models to find molecular targets like the centrosome and the KIFC1 motor protein. If promising molecules are found, they could guide future treatments or clinical tests.

Who could benefit from this research

Good fit: Ideal candidates would be people with chronic thrombocytopenia (low platelet counts) from causes such as immune thrombocytopenia, myelodysplastic syndromes, chemotherapy, surgery-related loss, or certain genetic disorders.

Not a fit: People whose bleeding is due to platelet function defects with normal counts, bleeding from non-platelet causes, or acute emergencies are unlikely to benefit directly from this basic lab research.

Why it matters

Potential benefit: If successful, this could point to new drug targets or methods to raise platelet counts, lowering bleeding risk and reducing the need for transfusions.

How similar studies have performed: Previous lab studies have shown that microtubules and motor proteins are important for making platelets, but targeting the centrosome and KIFC1 as a way to trigger platelet production is a newer, largely preclinical approach.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.